Sinclair Pharma Text-only version

Jump to navigation | Skip to content

Return to graphical version

Statements of Changes in Shareholders´ Equity
for the year ended 30 June 2008

 
Attributable
 
to equity
 
Share
Share
Merger
Other
Retained
holders of
Minority
Total
 
capital
premium
reserve
reserves
deficit
the parent
interest
equity
Group
£'000
£'000
£'000
£'000
£'000
£'000
£'000
£'000
Balance at 1 July 2006
933
21,386
50,404
749
(10,807)
62,655
5
62,670
Exchange differences arising
on translation of overseas subsidiaries
(478)
(478)
(478)
Net gain recognised directly in equity
(478)
(478)
(478)
Loss for the year
(4,208)
(4,208)
2
(4,206)
Total recognised
(expense)/income for the year
(478)
(4,208)
(4,686)
2
(4,684)
Share-based payments -
value of employee services
240
240
240
Options and warrants exercised
1
86
87
87
Share issue onpurchase of minority interest
1
70
71
4
75
Balance at 30 June 2007
935
21,472
50,474
271
(14,775)
58,377
11
58,388
Exchange differences arising
on translation of overseas subsidiaries
3,927
3,927
3,927
Net income recognised directly in equity
3,927
3,927
3,927
Profit for the year
3,337
3,337
1
3,338
Total recognised income for the year
3,927
3,337
7,264
1
7,265
Share-based payments -
value of employee services
678
678
678
Balance at 30 June 2008
935
21,472
50,474
4,198
(10,760)
66,319
12
66,331

 

           
Attributable
           
to equity
 
Share
Share
Merger
Other
Retained
holders of
 
capital
premium
reserve
reserves
deficit
the parent
Company
£'000
£'000
£'000
£'000
£'000
£'000
Balance at 1 July 2006
933
21,386
55,504
686
(2,573)
75,936
Loss for the year
(8,664)
(8,664)
Total recognised expense for the year
(8,664)
(8,664)
Share-based payments - value of employee services
240
240
Options and warrants exercised
1
86
87
Shares issued on purchase of minority interest
1
70
71
Balance at 30 June 2007
935
21,472
55,574
686
(10,997)
67,670
Profit for the year
149
149
Total recognised income for the year
149
149
Share-based payments - value of employee services
678
678
Balance at 30 June 2008
935
21,472
55,574
686
(10,170)
68,497

The notes pages 40 and 64 are an integral part of these consolidated financial statements.